Integrative phosphoproteomics defines two biologically distinct groups of KMT2A rearranged acute myeloid leukaemia with different drug response phenotypes
整合磷酸化蛋白质组学定义了两组生物学上不同的 KMT2A 重排急性髓系白血病,它们具有不同的药物反应表型
期刊:Signal Transduction and Targeted Therapy
影响因子:40.8
doi:10.1038/s41392-022-01288-1
Pedro Casado, Ana Rio-Machin, Juho J Miettinen, Findlay Bewicke-Copley, Kevin Rouault-Pierre, Szilvia Krizsan, Alun Parsons, Vinothini Rajeeve, Farideh Miraki-Moud, David C Taussig, Csaba Bödör, John Gribben, Caroline Heckman, Jude Fitzgibbon, Pedro R Cutillas